S.A. Johnson

Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia

The French Cooperative Group on CLL, S.A. Johnson, Alex Smith et al. · The Lancet · 1996 · 438 citations

Medicine, Immunology, Oncology +10

Long‐term follow‐up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis

Monica Else, Claire Dearden, Estella Matutes et al. · British Journal of Haematology · 2009 · 276 citations

Medicine, Pharmacology, Pharmacotherapy +8

Role of the Syk autophosphorylation site and SH2 domains in B cell antigen receptor signaling.

Tomohiro Kurosaki, S.A. Johnson, Lily Pao et al. · The Journal of Experimental Medicine · 1995 · 261 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Phosphorylated immunoreceptor signaling motifs (ITAMs) exhibit unique abilities to bind and activate Lyn and Syk tyrosine kinases

S.A. Johnson, Christopher M. Pleiman, Lily Pao et al. · The Journal of Immunology · 1995 · 224 citations

Life Sciences, Biochemistry, Immunology +17

Results of a Randomized Trial of Chlorambucil Versus Fludarabine for Patients With Untreated Waldenström Macroglobulinemia, Marginal Zone Lymphoma, or Lymphoplasmacytic Lymphoma

Véronique Leblond, S.A. Johnson, Sylvie Chevret et al. · Journal of Clinical Oncology · 2012 · 152 citations

Medicine, Oncology, Pharmacotherapy +15